文献速递临床试验与 GCP新药、器械与细胞基因治疗研发

ELEMENT试验:超声内镜引导胆道引流对比ERCP治疗恶性远端胆道梗阻的随机对照试验方案

ELEMENT TRIAL: study protocol for a randomized controlled trial on endoscopic ultrasound-guided biliary drainage of first intent with a lumen-apposing metal stent vs. endoscopic retrograde cholangio-pancreatography in the management of malignant distal biliary obstruction.
PubMed 文献 · Trials · 2019-12-09

ELEMENT试验为多中心单盲随机对照试验,计划纳入130例不可切除、局部晚期或临界可切除的恶性远端胆道梗阻患者,比较首选超声内镜引导胆管十二指肠吻合术(使用专用胆道腔道金属支架)与标准ERCP的疗效。主要终点为需再次干预的支架功能障碍发生率,旨在评估EUS-BD作为一线引流方式是否优于ERCP。

要点

  • 首次以RCT评估专用LAMS行EUS引导胆管十二指肠吻合术对比ERCP一线治疗恶性远端胆道梗阻。
  • 主要终点为需再次干预的支架功能障碍发生率,计划样本量130例。
  • 纳入不可切除、局部晚期或临界可切除恶性远端胆道梗阻患者,排除肝门梗阻、可切除肿瘤或良性疾病。

核心结论

  • ELEMENT试验旨在评估专用LAMS行EUS引导胆管十二指肠吻合术作为一线内镜引流是否优于传统ERCP治疗恶性远端胆道梗阻。

研究设计与样本

  • 多中心单盲随机对照试验,在加拿大9个中心纳入130例患者,按1:1比例以区组大小4随机分配至EUS-胆管十二指肠吻合术(LAMS)组或ERCP(传统金属支架)组。
  • 纳入标准为不可切除、局部晚期或临界可切除的恶性远端胆道梗阻且符合入排标准者;排除肝门梗阻、可切除肿瘤或良性疾病患者。

关键数值与推荐

  • 主要终点为需再次干预的支架功能障碍发生率。
  • 次要结局包括技术成功与临床成功、化疗中断、手术切除率、支架功能障碍时间和不良事件。

临床怎么用

  • 若试验证实EUS引导胆管十二指肠吻合术使用专用LAMS优于ERCP,可能改变恶性远端胆道梗阻的一线内镜引流策略。

局限性

  • 原文指出EUS-BD发展受限于缺乏多中心随机对照试验和专用器械,该问题尚未以RCT设计解决。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND & AIMS: Endoscopic ultrasound guided-biliary drainage (EUS-BD) is a promising alternative to endoscopic retrograde cholangiopancreatography (ERCP); however, its growth has been limited by a lack of multicenter randomized controlled trials (RCT) and dedicated devices. A dedicated EUS-BD lumen- apposing metal stent (LAMS) has recently been developed with the potential to greatly facilitate the technique and safety of the procedure. We aim to compare a first intent approach with EUS-guided choledochoduodenostomy with a dedicated biliary LAMS vs. standard ERCP in the management of malignant distal biliary obstruction. METHODS: The ELEMENT trial is a multicenter single-blinded RCT involving 130 patients in nine Canadian centers. Patients with unresectable, locally advanced, or borderline resectable malignant distal biliary obstruction meeting the inclusion and exclusion criteria will be randomized to EUS-choledochoduodenostomy using a LAMS or ERCP with traditional metal stent insertion in a 1:1 proportion in blocks of four. Patients with hilar obstruction, resectable cancer, or benign disease are excluded. The primary endpoint is the rate of stent dysfunction needing re-intervention. Secondary outcomes include technical and clinical success, interruptions in chemotherapy, rate of surgical resection, time to stent dysfunction, and adverse events. DISCUSSION: The ELEMENT trial is designed to assess whether EUS-guided choledochoduodenostomy using a dedicated LAMS is superior to conventional ERCP as a first-line endoscopic drainage approach in malignant distal biliary obstruction, which is an important and timely question that has not been addressed using an RCT study design. TRIAL REGISTRATION: Registry name: ClinicalTrials.gov. Registration number: NCT03870386. Date of registration: 03/12/2019.

来源:Trials,查看原文。版权归原作者所有。

引用

  1. Chen YI, Callichurn K, Chatterjee A, et al. ELEMENT TRIAL: study protocol for a randomized controlled trial on endoscopic ultrasound-guided biliary drainage of first intent with a lumen-apposing metal stent vs. endoscopic retrograde cholangio-pancreatography in the management of malignant distal biliary obstruction. Trials. 2019. PMID: 31818329. doi:10.1186/s13063-019-3918-y

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。